Literature DB >> 21072666

The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+ -activated large-conductance K+ channels in endothelial cells.

Alexander I Bondarenko1, Rolland Malli, Wolfgang F Graier.   

Abstract

Lysophospholipids are known to serve as intra- and extracellular messengers affecting many physiological processes. Lysophosphatidylinositol (LPI), which is produced in endothelial cells, acts as an endogenous agonist of the orphan receptor, G protein-coupled receptor 55 (GPR55). Stimulation of GPR55 by LPI evokes an intracellular Ca(2+) rise in several cell types including endothelial cells. In this study, we investigated additional direct, receptor-independent effects of LPI on endothelial large-conductance Ca(2+) and voltage-gated potassium (BK(Ca)) channels. Electrophysiological experiments in the inside-out configuration revealed that LPI directly affects the BK(Ca) channel gating properties. This effect of LPI strictly depended on the presence of Ca(2+) and was concentration-dependent, reversible, and dual in nature. The modulating effects of LPI on endothelial BK(Ca) channels correlated with their initial open probability (Po): stimulation at low Po (<0.3) and inhibition at high Po levels (>0.3). In the whole-cell configuration, LPI in the pipette facilitated membrane hyperpolarization in response to low (0.1-2 μM) histamine concentrations. In contrast, LPI counteracted membrane hyperpolarization in response to supramaximal cell stimulation with histamine. These results highlight a novel receptor-independent and direct bidirectional modulation of BK(Ca) channels by LPI on endothelial cells. We conclude that LPI via this mechanism serves as an important modulator of endothelial electrical responses to cell stimulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21072666      PMCID: PMC3014879          DOI: 10.1007/s00424-010-0898-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  45 in total

1.  Endothelial K(+) channel lacks the Ca(2+) sensitivity-regulating beta subunit.

Authors:  J Papassotiriou; R Köhler; J Prenen; H Krause; M Akbar; J Eggermont; M Paul; A Distler; B Nilius; J Hoyer
Journal:  FASEB J       Date:  2000-05       Impact factor: 5.191

Review 2.  Direct effects of fatty acids and other charged lipids on ion channel activity in smooth muscle cells.

Authors:  S Petrou; R W Ordway; M T Kirber; A M Dopico; J A Hamilton; J V Walsh; J J Singer
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1995 Feb-Mar       Impact factor: 4.006

3.  Bradykinin-induced potassium current in cultured bovine aortic endothelial cells.

Authors:  M Colden-Stanfield; W P Schilling; L D Possani; D L Kunze
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

4.  Dual effect of tamoxifen on arterial KCa channels does not depend on the presence of the beta1 subunit.

Authors:  Guillermo J Pérez
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

5.  Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.

Authors:  Z Shen; M Wu; P Elson; A W Kennedy; J Belinson; G Casey; Y Xu
Journal:  Gynecol Oncol       Date:  2001-10       Impact factor: 5.482

6.  GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.

Authors:  Alexander Bondarenko; Markus Waldeck-Weiermair; Shamim Naghdi; Michael Poteser; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.

Authors:  Christoph Rüdiger Wolfram Kuhlmann; Dörte Wiebke Lüdders; Christian Alexander Schaefer; Astrid Kerstin Most; Ulrich Backenköhler; Thomas Neumann; Harald Tillmanns; Ali Erdogan
Journal:  J Mol Cell Cardiol       Date:  2004-05       Impact factor: 5.000

8.  Activation of a small-conductance Ca(2+)-dependent K+ channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells.

Authors:  K Groschner; W F Graier; W R Kukovetz
Journal:  Biochim Biophys Acta       Date:  1992-10-27

Review 9.  Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.

Authors:  Ji Woong Choi; Chang-Wook Lee; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2008-03-25

10.  Cyclic AMP enhances agonist-induced Ca2+ entry into endothelial cells by activation of potassium channels and membrane hyperpolarization.

Authors:  W F Graier; W R Kukovetz; K Groschner
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

View more
  16 in total

1.  Lysophosphatidylinositol stimulates [³⁵S]GTPγS binding in the rat prefrontal cortex and hippocampus.

Authors:  Maria Luisa Rojo; Antonio Rodriguez-Gaztelumendi; Christopher J Fowler
Journal:  Neurochem Res       Date:  2012-01-22       Impact factor: 3.996

Review 2.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 3.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Julia Kargl; Clara Andradas; Andrew J Brown; Andrew Irving; Cristina Sanchez; Maria Waldhoer
Journal:  Mol Endocrinol       Date:  2011-09-29

4.  The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.

Authors:  Haleli Sharir; Linda Console-Bram; Christina Mundy; Steven N Popoff; Ankur Kapur; Mary E Abood
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

5.  The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.

Authors:  Y M AlSuleimani; C R Hiley
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

6.  Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.

Authors:  Justine Yu; Elena Deliu; Xue-Quian Zhang; Nicholas E Hoffman; Rhonda L Carter; Laurel A Grisanti; G Cristina Brailoiu; Muniswamy Madesh; Joseph Y Cheung; Thomas Force; Mary E Abood; Walter J Koch; Douglas G Tilley; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

7.  Direct activation of Ca2+ and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor.

Authors:  Alexander I Bondarenko; Olga Panasiuk; Iryna Okhai; Fabrizio Montecucco; Karim J Brandt; Francois Mach
Journal:  Eur J Pharmacol       Date:  2017-03-19       Impact factor: 4.432

8.  GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na+-Ca2+ exchanger and endoplasmic reticulum Ca2+ refilling.

Authors:  Alexander I Bondarenko; Fabrizio Montecucco; Olga Panasiuk; Vadim Sagach; Nataliya Sidoryak; Karim J Brandt; François Mach
Journal:  Vascul Pharmacol       Date:  2017-01-05       Impact factor: 5.773

9.  The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction.

Authors:  Andras T Deak; Lukas N Groschner; Muhammad Rizwan Alam; Elisabeth Seles; Alexander I Bondarenko; Wolfgang F Graier; Roland Malli
Journal:  J Cell Sci       Date:  2012-12-13       Impact factor: 5.285

10.  N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.

Authors:  Alexander I Bondarenko; Konstantin Drachuk; Olga Panasiuk; Vadim Sagach; Andras T Deak; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.